Virilization without adrenal hyperplasia in 21-hydroxylase deficiency during fetal life. 1984

U Kuhnle, and N Böhm, and G Wolff, and A Mayerová, and H G Dörr, and F Bidlingmaier, and D Knorr

The characteristic excess production of androgens in the cortisol 21-hydroxylase defect is generally considered to be secondary to ACTH stimulation of alternate pathways. Whenever a morphological examination of the adrenals has been possible in this disorder, adrenocortical hyperplasia was a constant finding. The availability of methods for the prenatal diagnosis of the 21-hydroxylase defect has made it possible to examine some of the manifestations of this disorder during fetal life. We studied a severely virilized 20-week-old aborted female fetus with the 21-hydroxylase defect whose adrenals were neither grossly enlarged nor microscopically hyperplastic. In a pregnancy at risk for congenital adrenal hyperplasia due to a 21-hydroxylase deficiency, amniocentesis was performed in the 18th week of gestation. The 21-hydroxylase defect was established by HLA typing and highly elevated levels of 17-hydroxyprogesterone, testosterone, and androstendione in amniotic fluid. After counselling, the parents, who already had a girl with the salt-wasting form of 21-hydroxylase deficiency, wished termination of the pregnancy. The aborted 20-week-old fetus was within the normal range for gestational age in weight and height. The external genitalia were ambiguous and extremely virilized, with an enlarged clitoris and fused labioscrotal folds. A urogenital sinus opened at the base of the clitoris. The internal organs were female, with a normal uterus and ovaries. Both adrenals were normal in size and weight for their gestational age. Histological examination of the adrenals revealed no abnormalities, and no hyperplasia was detectable. Thus, the adrenals in the 21-hydroxylase defect during fetal life secrete excessive amounts of androgens and cause virilization in the absence of adrenocortical hyperplasia.

UI MeSH Term Description Entries
D007621 Karyotyping Mapping of the KARYOTYPE of a cell. Karyotype Analysis Methods,Analysis Method, Karyotype,Analysis Methods, Karyotype,Karyotype Analysis Method,Karyotypings,Method, Karyotype Analysis,Methods, Karyotype Analysis
D011247 Pregnancy The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH. Gestation,Pregnancies
D005260 Female Females
D005315 Fetal Diseases Pathophysiological conditions of the FETUS in the UTERUS. Some fetal diseases may be treated with FETAL THERAPIES. Embryopathies,Disease, Fetal,Diseases, Fetal,Embryopathy,Fetal Disease
D006680 HLA Antigens Antigens determined by leukocyte loci found on chromosome 6, the major histocompatibility loci in humans. They are polypeptides or glycoproteins found on most nucleated cells and platelets, determine tissue types for transplantation, and are associated with certain diseases. Human Leukocyte Antigen,Human Leukocyte Antigens,Leukocyte Antigens,HL-A Antigens,Antigen, Human Leukocyte,Antigens, HL-A,Antigens, HLA,Antigens, Human Leukocyte,Antigens, Leukocyte,HL A Antigens,Leukocyte Antigen, Human,Leukocyte Antigens, Human
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000312 Adrenal Hyperplasia, Congenital A group of inherited disorders of the ADRENAL GLANDS, caused by enzyme defects in the synthesis of cortisol (HYDROCORTISONE) and/or ALDOSTERONE leading to accumulation of precursors for ANDROGENS. Depending on the hormone imbalance, congenital adrenal hyperplasia can be classified as salt-wasting, hypertensive, virilizing, or feminizing. Defects in STEROID 21-HYDROXYLASE; STEROID 11-BETA-HYDROXYLASE; STEROID 17-ALPHA-HYDROXYLASE; 3-beta-hydroxysteroid dehydrogenase (3-HYDROXYSTEROID DEHYDROGENASES); TESTOSTERONE 5-ALPHA-REDUCTASE; or steroidogenic acute regulatory protein; among others, underlie these disorders. Congenital Adrenal Hyperplasia,Hyperplasia, Congenital Adrenal,Adrenal Hyperplasias, Congenital,Congenital Adrenal Hyperplasias,Hyperplasias, Congenital Adrenal
D013250 Steroid Hydroxylases Cytochrome P-450 monooxygenases (MIXED FUNCTION OXYGENASES) that are important in steroid biosynthesis and metabolism. Steroid Hydroxylase,Steroid Monooxygenases,Hydroxylase, Steroid,Hydroxylases, Steroid,Monooxygenases, Steroid
D014770 Virilism Development of male secondary SEX CHARACTERISTICS in the FEMALE. It is due to the effects of androgenic metabolites of precursors from endogenous or exogenous sources, such as ADRENAL GLANDS or therapeutic drugs. Androgenization,Virilization

Related Publications

U Kuhnle, and N Böhm, and G Wolff, and A Mayerová, and H G Dörr, and F Bidlingmaier, and D Knorr
January 1994, The Journal of steroid biochemistry and molecular biology,
U Kuhnle, and N Böhm, and G Wolff, and A Mayerová, and H G Dörr, and F Bidlingmaier, and D Knorr
January 2010, Neonatal network : NN,
U Kuhnle, and N Böhm, and G Wolff, and A Mayerová, and H G Dörr, and F Bidlingmaier, and D Knorr
January 1999, The Journal of clinical endocrinology and metabolism,
U Kuhnle, and N Böhm, and G Wolff, and A Mayerová, and H G Dörr, and F Bidlingmaier, and D Knorr
October 2011, Pediatric clinics of North America,
U Kuhnle, and N Böhm, and G Wolff, and A Mayerová, and H G Dörr, and F Bidlingmaier, and D Knorr
December 2009, Endocrinology and metabolism clinics of North America,
U Kuhnle, and N Böhm, and G Wolff, and A Mayerová, and H G Dörr, and F Bidlingmaier, and D Knorr
April 1988, Tanpakushitsu kakusan koso. Protein, nucleic acid, enzyme,
U Kuhnle, and N Böhm, and G Wolff, and A Mayerová, and H G Dörr, and F Bidlingmaier, and D Knorr
January 1995, The American journal of medicine,
U Kuhnle, and N Böhm, and G Wolff, and A Mayerová, and H G Dörr, and F Bidlingmaier, and D Knorr
January 1988, Annales de dermatologie et de venereologie,
U Kuhnle, and N Böhm, and G Wolff, and A Mayerová, and H G Dörr, and F Bidlingmaier, and D Knorr
January 2017, The Journal of steroid biochemistry and molecular biology,
U Kuhnle, and N Böhm, and G Wolff, and A Mayerová, and H G Dörr, and F Bidlingmaier, and D Knorr
December 2013, Clinical endocrinology,
Copied contents to your clipboard!